Literature DB >> 14688062

Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport.

Margarita M Camacho-Carvajal1, Sebastian Klingler, Felix Schnappauf, Sandra B Hake, Viktor Steimle.   

Abstract

Class II transactivator (CIITA), the master regulator of MHC class II (MHC-II) gene transcription, shows a complex behavior in terms of self-association, nucleo-cytoplasmic transport and MHC-II gene transactivation. Here, we analyzed the mechanisms of dominant-negative function and nucleo-cytoplasmic transport of CIITA with emphasis on the role of the C-terminal leucine-rich-repeat (LRR) region in these processes. First, we determined nucleo-cytoplasmic transport of endogenous CIITA and thus validated results obtained with epitope-tagged CIITA constructs. LRR mutations in potential protein-protein contact positions lead to either completely blocked or reduced nuclear import, but can also give rise to increased nuclear export. Surprisingly, N-terminally truncated CIITA mutants show dominant-negative inhibition of wild-type CIITA, whether they are located in the nucleus or in the cytoplasm. Integrity of the LRR is necessary for the dominant-negative function of both types of mutants. LRR mutations are dominant over the effect of an exogenously added N-terminal nuclear localization signal (NLS) leading to cytoplasmic localization. Taken together, our results show that the LRR regulate the function of one or several NLS within CIITA, and control both nuclear import and export. Self-association is not affected in these mutants; we therefore suggest that interaction of the LRR with an unknown protein partner may be necessary for import and transactivation function of CIITA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688062     DOI: 10.1093/intimm/dxh010

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  Expression regulation and function of NLRC5.

Authors:  Yikun Yao; Youcun Qian
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

2.  ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription.

Authors:  Wafa Al-Kandari; Srikarthika Jambunathan; Vandana Navalgund; Rupa Koneni; Margot Freer; Neeta Parimi; Rajini Mudhasani; Joseph D Fontes
Journal:  Mol Immunol       Date:  2006-04-04       Impact factor: 4.407

3.  Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.

Authors:  Lilien N Voong; Allison R Slater; Sebila Kratovac; Drew E Cressman
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

4.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

Review 5.  NLRC5, at the Heart of Antigen Presentation.

Authors:  Andreas Neerincx; Wilson Castro; Greta Guarda; Thomas A Kufer
Journal:  Front Immunol       Date:  2013-11-22       Impact factor: 7.561

6.  Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.

Authors:  Yves B Beaulieu; Jorge A Leon Machado; Sylvain Ethier; Luc Gaudreau; Viktor Steimle
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 7.  The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.

Authors:  Jorge Alfonso León Machado; Viktor Steimle
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

8.  PML promotes MHC class II gene expression by stabilizing the class II transactivator.

Authors:  Tobias Ulbricht; Mohammad Alzrigat; Almut Horch; Nina Reuter; Anna von Mikecz; Viktor Steimle; Eberhard Schmitt; Oliver H Krämer; Thomas Stamminger; Peter Hemmerich
Journal:  J Cell Biol       Date:  2012-09-24       Impact factor: 10.539

9.  Activation of ERα signaling differentially modulates IFN-γ induced HLA-class II expression in breast cancer cells.

Authors:  Ahmed A Mostafa; Dianne Codner; Kensuke Hirasawa; Yumiko Komatsu; Matthew N Young; Viktor Steimle; Sheila Drover
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.